Custom Search
Daclizumab News
New insights into how anti-rejection drug daclizumab helps MS patients
"Not only did the number of regulatory natural killer cells increase in patients treated with daclizumab, but that expansion correlated with the treatment outcome--the more these cells expanded, the better the MS patients did...
Roche and Protein Design Labs to jointly develop daclizumab in transplant maintenance therapy
Roche and Protein Design Labs, Inc. today announced an expansion to their partnership to co-develop and commercialize daclizumab for organ transplant patients on long-term, maintenance therapy.
NIH Researchers Discover Promising New Therapy for Blinding Eye Disease
A preliminary clinical trial, conducted by researchers at the National Institutes of Health (NIH), found that an investigational treatment for uveitis (pronounced yoo-vee-eye-tis) seems to have many fewer side effects than...
Displaying results 6 to 8 out of 8